[Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
Tomura
S
S
Department of Internal Medicine, Nakano General Hospital.
D000740:Anemia / Q000503:physiopathology* / Q000628:therapy; D001777:Blood Coagulation; D001794:Blood Pressure; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005342:Fibrinolysis; D006439:Hemodynamics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000628:therapy; D010974:Platelet Aggregation; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis; D014655:Vascular Resistance
D011994:Recombinant Proteins; D004921:Erythropoietin